ArticleClinical rheumatology2026
Identification and validation of key autophagy-related genes in Lupus nephritis.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectivesLupus nephritis (LN) is one of the most common complications of systemic lupus erythematosus. This study aimed to identify key autophagy-related genes and to provide a novel approach for the diagnosis and treatment of LN.
methodsGene expression profiles from the GEO database were analyzed to identify differentially expressed autophagy-related genes (DE-ARGs). Enrichment analysis and protein-protein interaction (PPI) networks for these DE-ARGs were conducted. The cytoHubba plug-in and machine learning methods were utilized to identify hub genes. Receiver operating characteristic (ROC) analyses were performed to evaluate the diagnostic value of these hub genes. The hub genes were further validated using external datasets and quantitative real-time polymerase chain reaction (qRT-PCR). Additionally, immune cell infiltration analysis was conducted to identify immune signatures in LN.
resultsA total of 18 DE-ARGs were identified. These genes are associated with the defense response to viruses and the RIG-I-like receptor signaling pathway. Among them, IFI27 was identified as a hub gene, validated using external datasets, and confirmed through qRT-PCR. The ROC analysis indicated that IFI27 gene could serve as a potential diagnostic biomarker. Furthermore, the IFI27 gene was associated with immune-infiltrated cells and might play a role in adaptive immune-related processes in LN.
conclusionsIFI27 may play an essential role in the pathogenesis of LN and has the potential to be a promising biomarker and therapeutic target for LN. Key Points • IFI27, as an autophagy-related gene, plays an essential role in the pathogenesis of LN. • IFI27 has the potential to be a promising biomarker and therapeutic target for LN.
Indexed as
Identifiers
41485172What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.